A carregar...

Effects of Controlled-Release Alpha Lipoic Acid In Lean, Nondiabetic Patients with Polycystic Ovary Syndrome

BACKGROUND: The purpose of this study was to determine whether a preparation of controlled-release alpha lipoic acid (CRLA) influences features of the polycystic ovary syndrome (PCOS). METHODS: We administered CRLA 600 mg twice daily for 16 weeks to six lean, nondiabetic patients with PCOS. Insulin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Masharani, Umesh, Gjerde, Christine, Evans, Joseph L., Youngren, Jack F., Goldfine, Ira D.
Formato: Artigo
Idioma:Inglês
Publicado em: Diabetes Technology Society 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2864173/
https://ncbi.nlm.nih.gov/pubmed/20307398
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!